Equitec Proprietary Markets »

Cidara Therapeutics shares owned by Equitec Proprietary Markets

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Equitec Proprietary Markets from 13F filings

Historical chart of Equitec Proprietary Markets investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Equitec Proprietary Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Equitec Proprietary Markets

Quarter filed Position value Share count Share price at filing
2025-12-31 $16M 74k 220.89

More positions owned by Equitec Proprietary Markets

Netflix Call Option (NFLX)
Cidara Therapeutics Com New Call Option (CDTX)
Hologic (HOLX)
Avadel Pharmaceuticals Com Shs Call Option (AVDL)
Paramount Skydance Corp Com Cl B (PSKY)
Warner Bros Discovery Com Ser A (WBD)
Electronic Arts Call Option (EA)
Boeing Company Put Option (BA)
Brighthouse Finl (BHF)
Western Midstream Partners L Com Unit Lp Int (WES)
Kayne Anderson Bdc Com Shs (KBDC)
Siriusxm Holdings Common Stock (SIRI)
Wolfspeed Common Stock Put Option (WOLF)
Dynavax Technologies Corp Com New (DVAX)
Strategy Cl A New Call Option (MSTR)

View all positions for Equitec Proprietary Markets

Top funds holding Cidara Therapeutics

RA Capital Management
Vanguard Group
BlackRock
BVF
UBS Group
Darwin Global Management
Vivo Capital
State Street Corporation
Susquehanna International
FMR
Leucadia National Corporation
Paradigm Biocapital Advisors
Citadel Advisors
Henderson Group
Glazer Capital

View all funds holding Cidara Therapeutics